Boston Scientific ACCOLADE pacemaker recall: do you need urgent replacement?
Usually not. For most patients with an affected Boston Scientific ACCOLADE-family pacemaker or CRT-P, the FDA’s May 7, 2026 Class I recall correction points to software updates and closer monitoring, not automatic urgent replacement.
Usually not. For most people with an affected Boston Scientific ACCOLADE-family pacemaker or CRT-P, the FDA’s May 7, 2026 Class I recall correction points to software updates and closer monitoring, not automatic urgent replacement.
On June 12, 2026, the FDA updated its safety communication to point readers to the newer recall correction notice. The agency also says general prophylactic replacement is not recommended.
What the FDA did
The FDA’s May 7 action is a Class I recall correction for certain Boston Scientific ACCOLADE-family pacemakers and cardiac resynchronization therapy pacemakers, or CRT-Ps. Class I is the FDA’s most serious recall category, but in this case the action is aimed at correcting affected devices and monitoring patients, not automatically removing every device.
The key practical message for patients is simple: do not assume a recall notice means you need emergency surgery. In most cases, the next step is device review, a software update when indicated, and continued follow-up.
Which devices are affected?
The FDA says the affected group includes ACCOLADE-family pacemakers and CRT-Ps sold under several Boston Scientific names, including Accolade, Essentio, Proponent, Altrua 2, Valitude, and Visionist. Your cardiology team can confirm whether your exact model and serial number are included.
For general background, pacemakers help control abnormal heart rhythms by sending electrical signals that help the heart beat at an appropriate rate. That is why a device problem can matter more for some patients than for others.
What Brady SMR6 means
Brady SMR6 is a software and firmware update that clinics apply during an in-person device check using a Boston Scientific programmer. In plain language, it is a correction intended to reduce risk and improve device behavior, not a replacement for the pacemaker itself.
The FDA says affected devices should be upgraded to Brady SMR6 when appropriate. Your care team can tell you whether that has already happened.
What most patients should do now
Most patients should keep their usual follow-up plan, stay in contact with their cardiology team, and ask whether they should be monitored remotely or in the office. If you use remote monitoring, your clinic may be able to track device status without waiting for the next visit.
At your next appointment, ask:
- Is my exact device part of this FDA recall correction?
- Has my device already been updated to Brady SMR6?
- Am I enrolled in remote monitoring?
- How much battery longevity remains?
- Do you consider me at higher risk if the device enters Safety Mode?
Who may need faster replacement or closer follow-up?
Some patients may need faster action than others, especially if they are pacemaker-dependent, have a CRT-P or dual-chamber extended-life device, or have less battery longevity left. The exact timing depends on the individual device, the patient’s pacing needs, and whether the device has already been updated.
That does not mean everyone in a higher-risk group needs immediate replacement. It means the decision may need to move faster after a cardiologist reviews the full device report.
Symptoms to take seriously
The FDA advises patients to contact their health care provider if they have new or worsening lightheadedness or if they have questions about possible Safety Mode. If someone faints or loses consciousness, seek emergency care right away.
What is known, and what is not
What is known: the FDA treated this as a serious recall correction, and the current response centers on software correction, monitoring, and individualized follow-up rather than blanket device removal.
What is not known for any one patient: exactly how soon a replacement would be needed, or whether replacement is needed at all. That depends on the device model, remaining battery life, pacing dependence, and the findings from follow-up checks.
Short checklist for your cardiology visit
- Bring your device card if you have it.
- Ask whether your device is included in the recall correction.
- Ask whether Brady SMR6 has been installed.
- Confirm whether remote monitoring is active.
- Ask what symptoms should prompt you to call sooner.
- Ask whether your battery longevity changes your follow-up timing.
For most families, the takeaway is straightforward: a recall correction does not automatically mean urgent device removal. It does mean your cardiology team should confirm your device status, monitoring plan, and any needed update.
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
